Saha Chaitrali, Kothapalli Prathap, Patil Veerupaxagouda, ManjunathaReddy Gundallahalli Bayyappa, Kaveri Srini V, Bayry Jagadeesh
Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Université Paris Descartes, Paris, France.
UMR CNRS 6022, Université de Technologie de Compiègne, Compiègne, France.
Hum Vaccin Immunother. 2020;16(2):233-239. doi: 10.1080/21645515.2019.1602434. Epub 2019 May 7.
Intravenous immunoglobulin (IVIG) is one of the widely used immunotherapeutic molecules in the therapy of autoimmune and inflammatory diseases. Previous reports demonstrate that one of the anti-inflammatory actions of IVIG implicates suppression of macrophage activation and release of their inflammatory mediators. However, macrophages are highly plastic and depending on the microenvironmental signals, macrophages can be polarized into pro-inflammatory classic (M1) or anti-inflammatory alternative (M2) type. This plasticity of macrophages raised additional questions on the role of IVIG towards macrophage polarization. In the present report, we show that IVIG affects the polarization of both classically and alternatively activated macrophages and this process is F(ab')-independent. Our data thus indicate the lack of reciprocal regulation of inflammatory and non-inflammatory macrophages by IVIG.
静脉注射免疫球蛋白(IVIG)是治疗自身免疫性疾病和炎症性疾病时广泛使用的免疫治疗分子之一。先前的报告表明,IVIG的抗炎作用之一涉及抑制巨噬细胞活化及其炎症介质的释放。然而,巨噬细胞具有高度可塑性,根据微环境信号,巨噬细胞可极化为促炎经典型(M1)或抗炎替代型(M2)。巨噬细胞的这种可塑性引发了关于IVIG对巨噬细胞极化作用的更多问题。在本报告中,我们表明IVIG影响经典活化和替代活化巨噬细胞的极化,并且这一过程不依赖于F(ab')。因此,我们的数据表明IVIG对炎症性和非炎症性巨噬细胞缺乏相互调节作用。